Astonea Labs Ltd vs Speciality Medicines Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 07, 2026

Key Highlights

The Latest Trading Price of Astonea Labs Ltd is ₹ 174 as of 07 May 15:30 . The P/E Ratio of Astonea Labs Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Speciality Medicines Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 years The Market Cap of Astonea Labs Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Speciality Medicines Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 years The Dividend Payout of Astonea Labs Ltd changed from 0 % on March 2022 to 0 % on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe Dividend Payout of Speciality Medicines Ltd changed from 0 % on March 2022 to 0 % on March 2025 . This represents a CAGR of 0.0% over 4 years .

About Astonea Labs Ltd

Astonea Labs Limited was originally incorporated as 'AHU Laboratories Private Limited', as a private limited company, pursuant to certificate of incorporation dated April 11, 2017.
Company changed its name from AHU Laboratories Limited to 'Astonea Labs Private Limited' dated February 26, 2019.
Subsequently, the Company further changed the name to 'Astonea Labs Limited', vide fresh Certificate of Incorporation dated January 11, 2024. Company specializes in the manufacturing and marketing of a wide range of pharmaceutical and cosmetic products.
These include antibiotic drugs, anticold medications, antihistamines, and drugs for diabetes, cardiovascular diseases, gynecological concerns, analgesics, fungal infections, and multivitamins.
These are used for skin, tooth, and hair care, available in various forms such as gels, ointments, creams, lotions, oils, and serums.

About Speciality Medicines Ltd

Speciality Medicines Limited was originally incorporated as 'Speciality Medicines Private Limited' as a Private Limited Company, dated February 05, 2021, issued by the Registrar of Companies, Central Registration Centre.
Later on, the status was converted to Public Limited and the name of the Company was changed to 'Speciality Medicines Limited' and a fresh Certificate of Incorporation dated June 25, 2024 was issued to the Company by Registrar of Companies. The Company is engaged in marketing & distribution of finished formulations of Specialty pharmaceuticals - high-cost oral or injectable medications used to treat complex chronic conditions in Domestic as well as International Market.
The Company has presence over 35 countries. The Company deal in Specialty pharmaceuticals finished formulations Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nasal Spray, Ointment, Ophthalmic, Oral Solution, Oral Suspension, Sachet, Suspension and Tablet.

FAQs for the comparison of Astonea Labs Ltd and Speciality Medicines Ltd

Which company has a larger market capitalization, Astonea Labs Ltd or Speciality Medicines Ltd?

Market cap of Astonea Labs Ltd is 182 Cr while Market cap of Speciality Medicines Ltd is 291 Cr

What are the key factors driving the stock performance of Astonea Labs Ltd and Speciality Medicines Ltd?

The stock performance of Astonea Labs Ltd and Speciality Medicines Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Astonea Labs Ltd and Speciality Medicines Ltd?

As of May 7, 2026, the Astonea Labs Ltd stock price is INR ₹174.0. On the other hand, Speciality Medicines Ltd stock price is INR ₹332.0.

How do dividend payouts of Astonea Labs Ltd and Speciality Medicines Ltd compare?

To compare the dividend payouts of Astonea Labs Ltd and Speciality Medicines Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.